Barriers to autopsy: Creutzfeldt-Jakob disease in New York State

Neuroepidemiology

Volumn 26, Issue 4, 2006, Pages 207-211

  Lillquist, Patricia P ^a   Thomas, Nadia ^a   Belay, Ermias D ^b   Schonberger, Lawrence B ^b   Morse, Dale ^a  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Autopsy; Autopsy view; Barriers; Creutzfeldt Jakob disease; Physicians

Indexed keywords

ARTICLE; AUTOPSY; BRAIN BIOPSY; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC ACCURACY; FAMILY ATTITUDE; HEALTH CARE FACILITY; HEALTH SURVEY; HUMAN; INFECTION CONTROL; PATHOLOGIST; PRION DISEASE; UNITED STATES;

ATTITUDE OF HEALTH PERSONNEL; AUTOPSY; COMMUNICABLE DISEASE CONTROL; CREUTZFELDT-JAKOB SYNDROME; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFORMED CONSENT; LEGAL GUARDIANS; NEUROLOGY; NEW YORK; PATHOLOGY;

EID: 33745035726     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092794     Document Type: Article

References (16)

1. Holman RC, Khan AS, Belay ED, Schonberger LB: Creutzfeldt-Jakob disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases. Emerg Infect Dis 1996;2:333-337.
2. Ironside JW, Bell JE: The 'high-risk' neuropathological autopsy in AIDS and Creutzfeldt-Jakob disease: principles and practice. Neuropathol Appl Neurobiol 1996;22:388-393.
3. Donahue JE, Hanna PA, Hariharan, S: Autopsy-proven Creutzfeldt-Jakob disease in a patient with a negative 14-3-3 assay and nonspecific EEG and MRI. Neurol Sci 2004;24:411-413.
4. Shojania K, Burton E, McDonald K, Goldman L: The Autopsy as an Outcome and Performance Measure. Evidence Report/Technology Assessment No. 58, AHRQ Publication No. 03-E002. Rockville, Agency for Healthcare Research and Quality, 2002.
5. Sinard JH: Factors affecting autopsy rates, autopsy request rates, and autopsy findings at a large academic medical center. Exp Mol Pathol 2001;70:333-343.
6. Heckerling PS, Williams MJ: Attitudes of funeral directors and embalmers toward autopsy. Arch Pathol Lab Med 1992;116:1147-1151.
7. Start RD, Dube A, Cross SS, Underwood JC: Funeral directors, mortuaries and necropsies: implications for necropsy consent rates and the prevention of infection. J Clin Pathol 1996;49:217-222.
8. Connell CM, Avey H, Holmes SB: Attitudes about autopsy: implications for educational interventions. Gerontologist 1994;34:665-673.
9. Rosenbaum GE, Burns J, Johnson J, Mitchell C, Robinson M, Truog RD: Autopsy consent practice at US teaching hospitals: results of a national survey. Arch Intern Med 2000;160:374-380.
10. Start RD, Dube A, Cross SS, Underwood JC: Does funeral preference influence clinical necropsy request outcome? Med Sci Law 1997;37:337-340.
11. Cochran EJ, Gostanian OM, Mirra SS: Autopsy practices at CERAD and Alzheimer disease center sites: a survey of neuropathologists. Alzheimer Dis Assoc Disord 1995;9:203-207.
12. Bonner GJ, Darkwa OK, Gorelick PB: Autopsy recruitment program for African Americans. Alzheimer Dis Assoc Disord 2000;14:202-208.
13. Steigman CK: The autopsy as a quality assurance tool: last rites or resurrection? MLO Med Lab Obs 2002;34:28-33.
14. Louie JK, Gavali SS, Belay ED, Trevejo R, Hammond LH, Schonberger LB, Vugia DJ: Barriers to Creutzfeldt-Jakob disease autopsies, California. Emerg Infect Dis 2004;10:1677-1680.
15. Urbach H, Klisch J, Wolf HK, Brechtelsbauer D, Gass S, Solymosi L: MRI in sporadic Creutzfeldt-Jakob disease: correlation with clinical and neuropathological data. Neuroradiology 1998;40:65-70.
16. Mittal S, Farmer P, Kalina P, Kingsley PB, Halperin J: Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt-Jakob disease. Arch Neurol 2002;59:128-134.